Self-Assembled Peptide Hydrogels Loaded with Umbilical Cord-Derived Mesenchymal Stem Cells Repairing Injured Endometrium and Restoring Fertility.
Xue LvWenjing NiuBin ZhangJingbo ChenShicong YangYuhuan XueYutian DongPeiyan YuanYue PanJeremy TanYi Yan YangXin DingXiaomiao ZhaoPublished in: Advanced healthcare materials (2024)
Endometrial injury is a major cause of infertility and recurrent miscarriage. However, no clinically available methods currently exist to effectively repair the damaged endometrium. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic approach for promoting tissue regeneration, yet a biocompatible scaffold capable of delivering MSCs and supporting their growth is needed. Herein, the study reports a peptide hydrogel scaffold, self-assembled from a peptide IVK8-RGD consisting of an ionic complementary peptide sequence IEVEIRVK and a bioactive sequence RGD, to load umbilical cord-derived mesenchymal stem cells (UC-MSCs). This peptide forms a hydrogel under the physiological condition through self-assembly, and the peptide hydrogel exhibits injectability and adhesiveness to uterus, making it suitable for endometrial repair. Importantly, this hydrogel supports the adhesion and proliferation of UC-MSCs in a 3D environment. In vivo experiments using rats with endometrial injury have shown that treatment with IVK8-RGD hydrogel loaded with UC-MSCs effectively restores endometrial thickness, inhibits fibrosis, and facilitates angiogenesis through activating Raf/MEK/ERK pathway, leading to significantly improved fertility and live birth rate. These findings demonstrate the potential of the UC-MSCs-loaded hydrogel in repairing damaged endometrium and may address the unmet clinical needs of treating recurrent miscarriage and infertility induced by endometrial damage.
Keyphrases
- umbilical cord
- mesenchymal stem cells
- drug delivery
- wound healing
- tissue engineering
- hyaluronic acid
- bone marrow
- cancer therapy
- drug release
- endometrial cancer
- signaling pathway
- cell therapy
- stem cells
- emergency department
- pregnant women
- type diabetes
- ionic liquid
- polycystic ovary syndrome
- oxidative stress
- pi k akt
- pseudomonas aeruginosa
- cell proliferation
- risk assessment
- human health
- staphylococcus aureus
- replacement therapy